Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain.
Center for Biomedical Research Network in Respiratory Diseases, Madrid, Spain.
JMIR Mhealth Uhealth. 2020 Apr 13;8(4):e16395. doi: 10.2196/16395.
Home-based noninvasive ventilation has proven cost-effective. But, adherence to therapy still constitutes a common clinical problem. We hypothesized that a behavioral intervention supported by a mobile health (mHealth) app could enhance patient self-efficacy. It is widely accepted that mHealth-supported services can enhance productive interactions among the stakeholders involved in home-based respiratory therapies.
This study aimed to measure changes in self-efficacy in patients with chronic respiratory failure due to diverse etiologies during a 3-month follow-up period after the intervention. Ancillary objectives were assessment of usability and acceptability of the mobile app as well as its potential contribution to collaborative work among stakeholders.
A single-blind, single-center, randomized controlled trial was conducted between February 2019 and June 2019 with 67 adult patients with chronic respiratory failure undergoing home-based noninvasive ventilation. In the intervention group, a psychologist delivered a face-to-face motivational intervention. Follow-up was supported by a mobile app that allowed patients to report the number of hours of daily noninvasive ventilation use and problems with the therapy. Advice was automatically delivered by the mobile app in case of a reported problem. The control group received usual care. The primary outcome was the change in the Self Efficacy in Sleep Apnea questionnaire score. Secondary outcomes included app usability, app acceptability, continuity of care, person-centered care, and ventilatory parameters.
Self-efficacy was not significantly different in the intervention group after the intervention (before: mean 3.4, SD 0.6; after: mean 3.4, SD 0.5, P=.51). No changes were observed in adherence to therapy nor quality of life. Overall, the mHealth tool had a good usability score (mean 78 points) and high acceptance rate (mean score of 7.5/10 on a Likert scale). It was considered user-friendly (mean score of 8.2/10 on a Likert scale) and easy to use without assistance (mean score of 8.5/10 on a Likert scale). Patients also scored the perception of continuity of care and person-centered care as high.
The integrated care intervention supported by the mobile app did not improve patient self-management. However, the high acceptance of the mobile app might indicate potential for enhanced communication among stakeholders. The study identified key elements required for mHealth tools to provide effective support to collaborative work and personalized care.
ClinicalTrials.gov NCT03932175; https://clinicaltrials.gov/ct2/show/NCT03932175.
家庭无创通气已被证明具有成本效益。但是,治疗依从仍然是一个常见的临床问题。我们假设,移动健康(mHealth)应用程序支持的行为干预可以增强患者的自我效能感。广泛认为,mHealth 支持的服务可以增强参与家庭呼吸治疗的利益相关者之间的富有成效的互动。
本研究旨在衡量在干预后 3 个月的随访期间,因不同病因导致慢性呼吸衰竭的患者自我效能感的变化。辅助目标是评估移动应用程序的可用性和可接受性,以及其对利益相关者协作工作的潜在贡献。
这是一项在 2019 年 2 月至 6 月间进行的单盲、单中心、随机对照试验,纳入 67 名接受家庭无创通气的慢性呼吸衰竭成年患者。在干预组中,一名心理学家进行了面对面的动机干预。随访由一个移动应用程序支持,该应用程序允许患者报告每天无创通气使用的时间和治疗中出现的问题。如果报告有问题,移动应用程序会自动提供建议。对照组接受常规护理。主要结局是睡眠呼吸暂停自我效能感问卷评分的变化。次要结局包括应用程序的可用性、应用程序的可接受性、护理连续性、以人为本的护理和通气参数。
干预后,干预组的自我效能感没有显著变化(干预前:平均 3.4,标准差 0.6;干预后:平均 3.4,标准差 0.5,P=.51)。治疗依从性和生活质量均未发生变化。总体而言,移动健康工具具有良好的可用性评分(平均 78 分)和高接受率(Likert 量表平均评分 7.5/10)。它被认为是用户友好的(Likert 量表平均评分 8.2/10),无需帮助即可轻松使用(Likert 量表平均评分 8.5/10)。患者还对连续性护理和以人为本的护理的感知给予了较高的评分。
移动应用程序支持的综合护理干预并未改善患者的自我管理。然而,移动应用程序的高接受度可能表明利益相关者之间的沟通有增强的潜力。该研究确定了移动健康工具为协作工作和个性化护理提供有效支持所需的关键要素。
ClinicalTrials.gov NCT03932175;https://clinicaltrials.gov/ct2/show/NCT03932175。